Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin de Bock

Showing results (71-80 of 89) with videos related to

Pageof 9
Sort By:
Diabetes Technology & Therapeutics|February 21, 2025
A Call-to-Action to Eliminate Barriers to Accessing Automated Insulin Delivery Systems for People with Type 1 DiabetesBanshi Saboo, Satish Garg, Richard M Bergenstal, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 26, 2021
Learning challenges of healthcare professionals supporting open-source automated insulin deliveryHamish Crocket, Dana M Lewis, Mercedes Burnside, et al.
Journal of Diabetes Science and Technology|July 3, 2025
First in Human Feasibility Study: Automated Insulin Delivery Utilizing a Self-Adapting Algorithm in Adults With Type 1 and Type 2 DiabetesTom Wilkinson, Solita Donnelly, Claire Lever, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|July 31, 2015
Efficacy and safety of sirolimus in a neonate with persistent hypoglycaemia following near-total pancreatectomy for hyperinsulinaemic hypoglycaemiaMary B Abraham, Vinutha B Shetty, Glynis Price, et al.
Journal of Diabetes and Metabolic Disorders|March 5, 2026
Accelerating care, capacity and equity in automated insulin delivery systems for New Zealanders with type 1 diabetes: the ACCESS-AID study protocolJennifer T Gale, Alisa Boucsein, Jonathan Williman, et al.
Journal of Paediatrics and Child Health|July 21, 2017
Insulin regimens for newly diagnosed children with type 1 diabetes mellitus in Australia and New Zealand: A survey of current practiceDharrshinee Selvakumar, Hesham S Al-Sallami, Martin de Bock, et al.
Diabetes Technology & Therapeutics|February 21, 2023
Impact of Missing Data on the Accuracy of Glucose Metrics from Continuous Glucose Monitoring Assessed Over a 2-Week PeriodGrant J Smith, Mary B Abraham, Martin de Bock, et al.
BMJ Open|August 15, 2018
Effect of 6 months hybrid closed-loop insulin delivery in young people with type 1 diabetes: a randomised controlled trial protocolMartin de Bock, Sybil A McAuley, Mary Binsu Abraham, et al.
Journal of Diabetes and Metabolic Disorders|May 30, 2023
Interviews with Indigenous Māori with type 1 diabetes using open-source automated insulin delivery in the CREATE randomised trialMercedes Burnside, Tracy Haitana, Hamish Crocket, et al.
Diabetes Technology & Therapeutics|June 27, 2022
Snapshot of CGM Metrics in Adolescents and Adults Achieving Target HbA1c Versus Those Not Meeting Target HbA1cMary B Abraham, Grant J Smith, Janice M Fairchild, et al.
Pageof 9

Showing results (71-80 of 89) with videos related to

Sort By:
Pageof 9
Diabetes Technology & Therapeutics|February 21, 2025
A Call-to-Action to Eliminate Barriers to Accessing Automated Insulin Delivery Systems for People with Type 1 DiabetesBanshi Saboo, Satish Garg, Richard M Bergenstal, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|November 26, 2021
Learning challenges of healthcare professionals supporting open-source automated insulin deliveryHamish Crocket, Dana M Lewis, Mercedes Burnside, et al.
Journal of Diabetes Science and Technology|July 3, 2025
First in Human Feasibility Study: Automated Insulin Delivery Utilizing a Self-Adapting Algorithm in Adults With Type 1 and Type 2 DiabetesTom Wilkinson, Solita Donnelly, Claire Lever, et al.
Journal of Pediatric Endocrinology & Metabolism : JPEM|July 31, 2015
Efficacy and safety of sirolimus in a neonate with persistent hypoglycaemia following near-total pancreatectomy for hyperinsulinaemic hypoglycaemiaMary B Abraham, Vinutha B Shetty, Glynis Price, et al.
Journal of Diabetes and Metabolic Disorders|March 5, 2026
Accelerating care, capacity and equity in automated insulin delivery systems for New Zealanders with type 1 diabetes: the ACCESS-AID study protocolJennifer T Gale, Alisa Boucsein, Jonathan Williman, et al.
Journal of Paediatrics and Child Health|July 21, 2017
Insulin regimens for newly diagnosed children with type 1 diabetes mellitus in Australia and New Zealand: A survey of current practiceDharrshinee Selvakumar, Hesham S Al-Sallami, Martin de Bock, et al.
Diabetes Technology & Therapeutics|February 21, 2023
Impact of Missing Data on the Accuracy of Glucose Metrics from Continuous Glucose Monitoring Assessed Over a 2-Week PeriodGrant J Smith, Mary B Abraham, Martin de Bock, et al.
BMJ Open|August 15, 2018
Effect of 6 months hybrid closed-loop insulin delivery in young people with type 1 diabetes: a randomised controlled trial protocolMartin de Bock, Sybil A McAuley, Mary Binsu Abraham, et al.
Journal of Diabetes and Metabolic Disorders|May 30, 2023
Interviews with Indigenous Māori with type 1 diabetes using open-source automated insulin delivery in the CREATE randomised trialMercedes Burnside, Tracy Haitana, Hamish Crocket, et al.
Diabetes Technology & Therapeutics|June 27, 2022
Snapshot of CGM Metrics in Adolescents and Adults Achieving Target HbA1c Versus Those Not Meeting Target HbA1cMary B Abraham, Grant J Smith, Janice M Fairchild, et al.
Pageof 9